Logotype for Champion Iron Limited

Champion Iron (CIA) Q3 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Champion Iron Limited

Q3 2025 earnings summary

9 Jan, 2026

Executive summary

  • Produced over 3.6 million tons and sold just under 3.3 million tons of iron ore concentrate in Q3 FY2025, with revenue of $363.2M and EBITDA of $88.2M, despite a 14-day unplanned loadout stoppage impacting shipments and sales volumes.

  • Net income and EPS were negatively impacted by unrealized FX losses and lower-than-expected sales volumes, with EPS at $0.00 for the quarter.

  • DRPF project advanced on schedule and budget for December 2025 commissioning, with $69M invested in the quarter and $288M cumulative to date.

  • Entered a binding partnership with Nippon Steel (30%) and Sojitz (19%) for the Kami Project, initiating a definitive feasibility study expected by mid-2026.

  • No significant environmental issues reported; continued engagement with First Nations and local communities.

Financial highlights

  • Revenue for the quarter was $363.2M, with EBITDA at $88.2M and EBITDA margin of 24%.

  • Net income was $1.7M, down 91% sequentially and 99% year-over-year, impacted by a $21.1M unrealized FX loss.

  • Operating costs remained elevated at $78.7/dmt sold, with all-in sustaining cost at $93.9/dmt sold.

  • Cash and cash equivalents stood at $93.1M, with available liquidity of $595M at quarter-end.

  • Net cash decreased mainly due to dividend payments ($51.8M), significant CapEx for the DRPF project, and lower sales.

Outlook and guidance

  • DRPF project remains on track for December 2025 commissioning, expected to upgrade half of Bloom Lake’s capacity to DR quality pellet feed.

  • Kami Project feasibility study underway, with completion targeted for mid-2026 and up to $490M in partner contributions before further capital is needed.

  • CapEx run rate expected to normalize to around $60M per quarter, excluding DRPF, after recent elevated spending.

  • Liquidity expected to improve as 2.9M wmt of stockpiled concentrate is gradually sold.

  • First DR product contracts expected to be signed in late 2025, targeting sales in 2026.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more